2005
DOI: 10.1016/j.ahj.2005.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Schizophrenia and increased risks of cardiovascular disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

13
642
2
28

Year Published

2007
2007
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 949 publications
(685 citation statements)
references
References 48 publications
13
642
2
28
Order By: Relevance
“…This discrepancy is at least in part generally explained as being caused by increases in comorbid medical conditions in the mentally ill, particularly chronic illnesses such as diabetes (69) and cardiovascular disease (2, 1014). To alleviate these problems there have been reports of clinical interventions to improve health care in the seriously mentally ill with some success (15, 16).…”
Section: Objectivementioning
confidence: 99%
“…This discrepancy is at least in part generally explained as being caused by increases in comorbid medical conditions in the mentally ill, particularly chronic illnesses such as diabetes (69) and cardiovascular disease (2, 1014). To alleviate these problems there have been reports of clinical interventions to improve health care in the seriously mentally ill with some success (15, 16).…”
Section: Objectivementioning
confidence: 99%
“…Among these metabolic syndrome, already a concern in persons with schizophrenia based on life style risk factors, is a major concern with drugs that cause increased body mass index, hyperlipidemia, reduced insulin sensitivity, and are associated with an increased incidence of diabetes. Reduction in life span is great, and expected to worsen with increased exposure to pharmacological adverse effects (Hennekens et al, 2005;Auquier et al, 2006;Seeman, 2007;Colton and Manderscheid, 2006;Newcomer and Hennekens, 2007). In most respects, drug development for schizophrenia has not progressed appreciably since the introduction of chlorpromazine, a point which recently found emphasis in a large first episode clinical trial in Beijing comparing the original antipsychotic drug, chlorpromazine, with the only second generation drug with documented superiority, clozapine.…”
Section: Introductionmentioning
confidence: 99%
“…Patients with schizophrenia have other physical health problems that might be related to the BH response. For example, patients with schizophrenia are at increased risk of cardiovascular disease diabetes, hyerplipidemia, and hypertension (Hennekens et al, 2005;Marder et al, 2004). Perhaps one of these health problems (or their pharmacologic treatment) might explain the increase in the BH response in patients.…”
Section: Discussion Of Breath Hold Resultsmentioning
confidence: 99%